Research Paper Volume 16, Issue 9 pp 8000—8018
A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance
Figure 2. Correlation between LDHA expression and overall survival and disease-free survival in patients with different cancer types. (A) Using GEPIA2 to construct an overall survival (OS) map of LDHA expression. (B) Kaplan–Meier survival curves (OS) of patients with high or low LDHA expression in multiple human cancers (ACC, CESC, KIRC, LGG, LIHC, LUAD, PAAD, READ). (C) Using GEPIA2 to construct a disease-free survival (DFS) map of LDHA expression. (D) Kaplan–Meier survival curves (DFS) of patients with high or low LDHA expression in multiple human cancers (ACC, LGG, LUSC, PAAD, READ, SARC). The expression of LDHA was distinguished by different color lines. Red lines indicated high expression, and blue lines indicated low expression.